9
Feb 2026
Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a medical lie enters the system, can AI pass it on as if it were true?
9
Feb 2026
The viewpoint reviews conflicting evidence on alcohol consumption, highlighting discrepancies between observational studies, genetic analyses, and public health guidance. It concludes that large randomized trials comparing alcohol moderation versus cessation are needed to clarify long-term health effects.
9
Feb 2026
The legalization of cannabis and the start of retail sales of the drug in the US are linked to both a rise in its recreational use and concurrent use of tobacco, as well as a fall in sole tobacco use, finds an analysis of health behavioral data, published online in the journal Tobacco Control.
9
Feb 2026
Just over one in 10 deaths from a wide range of infectious diseases can be attributed to obesity worldwide, finds a major new study led by a University College London (UCL) researcher.
9
Feb 2026
From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine.
9
Feb 2026
Some men are resorting to obtaining testosterone replacement therapy (TRT) from underground sources due to significant barriers to accessing the therapy through formal medical channels, according to new Griffith University research.
9
Feb 2026
A long-standing Medicare policy meant to manage rehabilitation services in nursing homes may keep older Americans in hospitals longer than necessary without improving patient health or saving Medicare money, new research finds.
9
Feb 2026
A new study from McMaster University involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food.
9
Feb 2026
Pancreatic cancer has a lot of nerve. Notoriously tricky to detect, the disease also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation.
9
Feb 2026
A new randomized controlled study funded by the Crohn's & Colitis Foundation found that time-restricted feeding-a form of intermittent fasting-significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn's disease and overweight or obesity.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
